You are here: Industry Insights > COVID-19 vaccine

News List

Lancaster University intranasal vaccine offers promise to block COVID-19 where it starts worldpharmanews
August 10, 2021
Research by Lancaster University scientists to create a COVID-19 vaccine which can be administered through the nose has taken a significant step forward.
Pharmacovigilance Risk Assessment Committee (PRAC) meeting highlights, August 2021 europeanpharmaceuticalreview
August 10, 2021
The EMA’s drug safety committee (PRAC) recommends updating risks of Janssen COVID-19 Vaccine, though the benefit-risk balance remains unchanged.
Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine americanpharmaceuticalreview
August 10, 2021
Bavarian Nordic A/S reported initial results from the first-in-human trial of ABNCoV2, led by the PREVENT-nCoV consortium.
Phase 2 Trials from Akston COVID-19 Vaccine Candidate americanpharmaceuticalreview
August 09, 2021
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced that the first participants have been dosed in a Phase II open-label trial of AKS-452, its protein subunit COVID-19 vaccine candidate.
Moderna records $4.4bn total revenue in Q2 2021 pharmaceutical-technology
August 09, 2021
Moderna has reported total revenue of $4.4bn in the second quarter (Q2) of the fiscal year (FY) 2021, a surge from $67m in the same quarter last year.
India authorises J&J’s Covid-19 vaccine for emergency use pharmaceutical-technology
August 09, 2021
India has approved Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine for emergency use, expanding the total number of anti-SARS-CoV-2 vaccines authorised in the country to five.
Facility augmentation of Bharat Biotech and three other PSEs being supported for augmented production of Covaxin: Health Minister expresspharma
August 09, 2021
CDSCO puts in place system to fast track processing of application for clinical trial and approval for COVID-19 vaccines.
FDA to allow export of certain lots of AstraZeneca COVID-19 vaccine made at Baltimore plant firstwordpharma
August 09, 2021
The FDA said certain lots of AstraZeneca's COVID-19 vaccine manufactured at Emergent Biosolutions' Baltimore facility are fit to be shipped outside the US, as reported Financial Post.
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine prnasia
August 06, 2021
Novavax, Inc. today announced that the companies have filed regulatory submissions for emergency use authorization of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M™ adjuvant.
Gov’t launches study on COVID-19 vaccine dose interval for pregnant women pharmatimes
August 06, 2021
A new clinical trial investigating the optimal gap between first and second COVID-19 vaccine doses for pregnant women is set to launch in England 3rd.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page